Cargando…
Proton pump inhibitor use does not increase dementia and Alzheimer’s disease risk: An updated meta-analysis of published studies involving 642305 patients
Recent studies have indicated an increased risk of dementia and Alzheimer’s disease (AD) among people who consume proton pump inhibitors (PPIs), but the results of those studies are inconsistent. This meta-analysis aimed to explore the correction risk of dementia and AD among PPI users. The literatu...
Autores principales: | Song, Ya Qi, Li, Yong, Zhang, Su Li, Gao, Jie, Feng, Shun Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605652/ https://www.ncbi.nlm.nih.gov/pubmed/31265473 http://dx.doi.org/10.1371/journal.pone.0219213 |
Ejemplares similares
-
Proton pump inhibitors and the risk of Alzheimer’s disease and non-Alzheimer’s dementias
por: Torres-Bondia, Francisco, et al.
Publicado: (2020) -
Investigating the biosynthesis of Sch-642305 in the fungus Phomopsis sp. CMU-LMA
por: Trenti, Francesco, et al.
Publicado: (2020) -
Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis
por: Liao, Shengtao, et al.
Publicado: (2019) -
Proton pump inhibitors and dementia: what association?
por: Caetano, Catarina, et al.
Publicado: (2023) -
Endophytic Fungus Isolated From Achyrocline satureioides Exhibits Selective Antiglioma Activity—The Role of Sch-642305
por: Pedra, Nathalia Stark, et al.
Publicado: (2018)